Drug development takes a long time from initial science. There are currently very promising cures (not just treatments) in the pipeline for sickle cell disease, beta thalassemia, and certain kinds of blindness. 1/
Just the biochemistry of safely, effectively, and accurately delivering the crispr therapy to the cell nucleus is massively complex and potentially different for each application. 3/3
Comments